EGFR and cancer: Because Syk can associate with EGFR in keratinocytes [14] and altered EGFR internalisation and recycling can regulate drug sensitivity in cancer cells [60,61], we plan to further determine the role of Syk in EGFR trafficking, including receptor internalisation, receptor recycling to the plasma membrane, and degradation by lysosomes in the future.